Ctenodon fascicularis
Ctenodon fascicularis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Ctenodon fascicularis is a botanical species of significant interest due to its unique phytochemical profile. Research has identified key chemical constituents within the plant, including 2-Methoxymedicarpin, SG, and Secundiflorol G. Specifically, the root bark preparation has been highlighted for its potential bioactive properties. Scientific investigation has focused on the efficacy of these compounds under certain conditions related to Cervical Cancer. Consequently, this plant represents a promising subject for further pharmacological exploration.
- Synonyms
- Aeschynomene Mimosoides · Adesmia Mimosoides · 2 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Root
Classification
Common Names
Ctenodon fascicularis is a plant species recognized by many local communities under its common name, kabal-pich. This specific nomenclature helps bridge the gap between scientific classification and traditional botanical knowledge. By using the name kabal-pich, practitioners and researchers can more easily identify the plant within its natural habitat. Such naming conventions are essential for maintaining a clear connection between the flora and the people who interact with it. Understanding these regional identities enriches our overall appreciation of the plant's ecological and cultural significance.
Sources: Catalogue of Life (COL)
Synonyms
Ctenodon fascicularis is a plant species that has been subject to various botanical reclassifications over time. Its taxonomic history is marked by several synonymous names, including its classification as Adesmia mimosoides. Researchers have also previously identified this plant under the name Aeschynomene fascicularis. Furthermore, it has been linked to the synonyms Aeschynomene fruticosa and Aeschynomene mimosoides in scientific literature. These overlapping designations highlight the complex evolutionary and naming shifts within its botanical lineage.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Ctenodon fascicularis is a unique biological entity that belongs to the kingdom Plantae. Within this vast kingdom, it is specifically classified under the class Equisetopsida. The plant follows a distinct evolutionary lineage through the order Fabales. Furthermore, it is nested within the family Fabaceae, which highlights its botanical connections. Finally, this species is identified by its specific placement within the genus Ctenodon.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Ctenodon |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Ctenodon fascicularis maintains a broad and diverse geographic presence throughout North America and various regions of Mexico. Its distribution spans the central territories, reaching into the unique ecosystems of the Gulf coast. The species is also well-established in the northeast and northwest portions of the Mexican landscape. Furthermore, its range extends significantly into the southeast, showcasing its adaptability to different environments. This wide-reaching footprint highlights the plant's ability to thrive across multiple distinct habitats.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Ctenodon fascicularis grows in a distinct shrub form, providing structure to its local environment. This plant is entirely self-supporting, maintaining its upright posture without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Ctenodon fascicularis, also known as Aeschynomene fascicularis, serves as a significant source of bioactive chemical compounds. Research has revealed that this plant contains the pterocarpan known as 2-methoxymedicarpin within its root bark. Additionally, the species contains the isoflavan Secundiflorol G, a compound of particular interest in medicinal studies. This specific substance has demonstrated the ability to induce apoptosis in cervical cancer cells through both extrinsic and intrinsic pathways. Consequently, these findings highlight the plant's potential value in the development of new cancer treatments.
Conditions
Ctenodon fascicularis (identified in the text as Aeschynomene fascicularis) exhibits significant therapeutic potential through its effects on various cancer cell lines. The plant's extracts and isolated compounds demonstrate the ability to treat the Hep-2 cancer cell line. Research shows that specific components from the plant also treat the DU-145 cell line. Furthermore, the plant displays potent activity against the HeLa cell line. Finally, the medicinal properties of the plant are effective in treating the KB cell line.
Preparations
Ctenodon fascicularis is prepared as root bark to isolate bioactive compounds such as pterocarpans and isoflavans. Within the root bark of this plant, researchers have identified specific substances like aeschynocarpin and secundiflorol G. These isolated components are studied for their significant medicinal potential, particularly in treating cancer-like symptoms. For instance, the secundiflorol G found in the bark has demonstrated the ability to induce apoptosis in cervical cancer cells. Consequently, the preparation of this root bark serves as a vital step in discovering promising natural candidates for cancer treatment.
Parts used
Ctenodon fascicularis, often identified in botanical literature under the synonym Aeschynomene fascicularis, contains specific medicinal components located within its root structure. Research into Mayan traditional medicine has highlighted the importance of the plant's root bark in treating cancer-like symptoms. By extracting methanol from these roots, scientists have successfully isolated various bioactive compounds such as pterocarpans and spinochalcones. These specific constituents derived from the root have demonstrated significant cytotoxic and antiproliferative activities against several cancer cell lines. Consequently, the root of this plant serves as a vital source for discovering potential new therapeutic entities in oncology.